换一批
换一批Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.
作者：
关键词
PAI-1, plasminogen activator inhibitor-1PARP, poly (ADP-ribose) polymerasePI, propidium iodideTM5275cancer therapeuticsclear cell carcinoma of the ovaryovarian cancerplasminogen activator inhibitor-1plasminogen activator inhibitor-1 inhibitorsiRNA, small interfering RNAuPA, urokinase-type plasminogen activator
主题词
抗肿瘤药(Antineoplastic Agents);细胞周期(Cell Cycle);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因敲低技术(Gene Knockdown Techniques);人类(Humans);免疫组织化学(Immunohistochemistry);半数抑制浓度(Inhibitory Concentration 50);分子靶向治疗(Molecular Targeted Therapy);卵巢肿瘤(Ovarian Neoplasms);哌嗪类(Piperazines);纤溶酶原激活物抑制物1(Plasminogen Activator Inhibitor 1);纤溶酶原灭活剂(Plasminogen Inactivators);预后(Prognosis);RNA, 信使(RNA, Messenger);RNA, 小分子干扰(RNA, Small Interfering);增量调节(Up-Regulation)
DOI
10.1080/15384047.2014.1001271
PMID
25587663
发布时间
2024-05-20
- 浏览89
Cancer biology & therapy
253-60页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
